Love your morning cup of Joe? There’s been a lot of research in recent years looking at the potential cancer risk benefits of drinking coffee.
One of the most recent investigations that suggest coffee may offer cancer protection focused on endometrial cancer. Published in December, researchers at the Harvard School of Public Health evaluated the evidence on coffee and endometrial cancer risk. The review looked at a total of 16 population studies with 6,628 cases of endometrial cancer.
The results are promising for coffee drinkers: the authors found a 29 percent reduced risk for developing endometrial cancer when comparing individuals who drank the most coffee compared to those who drank the least. The researchers reported an 8 percent decrease in risk for each cup of coffee consumed daily. You can read more about the study here.
Yesterday, there were a lot of stories about a new AICR-supported study on coffee and prostate cancer. The study found that drinking six or more cups of coffee regularly reduced the risk of overall prostate cancer by 18 percent, and lethal prostate cancer by 60 percent.
The study was published in the Journal of the National Cancer Institute, and you can read more about it in yesterday’s post.
Julie Kasperzyk, PhD., an epidemiologist at the Harvard School of Public Health was one of the study authors. Julie’s research is partially supported by AICR. Here, she answers a few questions about the work.
Q: There have been other studies looking at coffee-prostate cancer risk that have found coffee does not have an effect, what is unique about this new study?
A: This is the first large, prospective study to look specifically at advanced and lethal prostate cancer. This is especially important because prostate cancer is such a heterogeneous disease, and we need to understand risk factors associated with more aggressive forms of the disease. In addition, most previous studies of coffee and prostate cancer are older and didn’t use modern methods of adjusting for possible confounders. Continue reading
Whether men drink caffeinated or decaf coffee, a large new AICR-supported study suggests that men who consistently drink a lot of it may reduce their risk of the most lethal form of prostate cancer.
The study was published in the online edition of the Journal of the National Cancer Institute.
Previous studies on coffee and prostate cancer have found neither increased nor decreased risk. The new JNCI study is unique in that it focused on the advanced form of the disease and is the largest to date.
This study tracked almost 48,000 U.S. men who reported how much coffee they drank every four years from 1986 to 2008. During the study period, 5,035 cases of prostate cancer were reported, including 642 fatal cases.
For all forms of prostate cancer, the study found that men who consumed six or more cups of coffee daily had nearly a 20 percent lower risk than non-drinkers. When focusing only on the deadly form of prostate cancer, the protective association was even stronger. Men who drank the most coffee had a 60 percent lower risk of developing lethal prostate cancer compared to non-coffee drinkers.